Spots Global Cancer Trial Database for renal cell carcinoma metastatic
Every month we try and update this database with for renal cell carcinoma metastatic cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Deferred Cytoreductive Nephrectomy in Synchronous Metastatic Renal Cell Carcinoma: The NORDIC-SUN-Trial | NCT03977571 | Kidney Cancer Renal Cell Carc... Synchronous Neo... | Cytoreductive n... Tissue sampling | 18 Years - | University of Aarhus | |
Cabozantinib Treatment Prior to Cytoreductive Nephrectomy in Patients With Advanced or Metastatic Renal Cells Cancer | NCT06377722 | Renal Cell Carc... Renal Cell Carc... Renal Cell Carc... | Cabozantinib | 18 Years - | Fundacion Oncosur | |
A Prospective Study to Evaluate the Implementation of Shared Decision Making Strategy for Renal Cell Cancer (RCC) | NCT05548621 | Renal Cell Carc... Renal Cell Carc... | Decision aid | 18 Years - | St. Antonius Hospital | |
A Study of Abemaciclib in Combination With Sunitinib in Metastatic Renal Cell Carcinoma | NCT03905889 | Renal Cell Carc... | Abemaciclib Sunitinib | 18 Years - | Brown University | |
Cabozantinib Treatment Prior to Cytoreductive Nephrectomy in Patients With Advanced or Metastatic Renal Cells Cancer | NCT06377722 | Renal Cell Carc... Renal Cell Carc... Renal Cell Carc... | Cabozantinib | 18 Years - | Fundacion Oncosur | |
Combined Aerobic and Resistance Exercise Training in Metastatic Renal Cell Carcinoma | NCT05103722 | Renal Cell Carc... | Combined Aerobi... | 18 Years - 99 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
A Study of Abemaciclib in Combination With Sunitinib in Metastatic Renal Cell Carcinoma | NCT03905889 | Renal Cell Carc... | Abemaciclib Sunitinib | 18 Years - | Brown University | |
Combined Aerobic and Resistance Exercise Training in Metastatic Renal Cell Carcinoma | NCT05103722 | Renal Cell Carc... | Combined Aerobi... | 18 Years - 99 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
TDM for Optimized Outcome in Patients With mRCC. | NCT04659343 | Kidney Cancer Renal Cell Carc... Drug Toxicity Drug Side Effec... Drug Mechanism | Measurement of ... | 18 Years - | University of Aarhus | |
Cabozantinib Treatment Prior to Cytoreductive Nephrectomy in Patients With Advanced or Metastatic Renal Cells Cancer | NCT06377722 | Renal Cell Carc... Renal Cell Carc... Renal Cell Carc... | Cabozantinib | 18 Years - | Fundacion Oncosur | |
TDM for Optimized Outcome in Patients With mRCC. | NCT04659343 | Kidney Cancer Renal Cell Carc... Drug Toxicity Drug Side Effec... Drug Mechanism | Measurement of ... | 18 Years - | University of Aarhus | |
Combined Aerobic and Resistance Exercise Training in Metastatic Renal Cell Carcinoma | NCT05103722 | Renal Cell Carc... | Combined Aerobi... | 18 Years - 99 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
A Web-mediated Follow-up With the Web-application KidneyPRO Versus Standard Follow-up for Patients With Advanced Renal Cell Carcinoma Treated With Axitinib/Pembrolizumab in First Line | NCT04764487 | Renal Cell Carc... | KidneyPRO standard follow... | 18 Years - | Weprom |